These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8207325)

  • 1. Studies on the ocular hypotensive effects of prostaglandin F2 alpha ester prodrugs and receptor selective prostaglandin analogs.
    Woodward DF; Chan MF; Burke JA; Cheng-Bennett A; Chen G; Fairbairn CE; Gac T; Garst ME; Gluchowski C; Kaplan LJ
    J Ocul Pharmacol; 1994; 10(1):177-93. PubMed ID: 8207325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
    Woodward DF; Chan MF; Cheng-Bennett A; Wheeler LA; Chen G; Burke JA; Kharlamb A; Lai RK; Shan T
    Exp Eye Res; 1996 Oct; 63(4):411-23. PubMed ID: 8944548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies.
    Woodward DF; Lawrence RA; Fairbairn CE; Shan T; Williams LS
    J Lipid Mediat; 1993; 6(1-3):545-53. PubMed ID: 8358015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
    Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on a novel series of acyl ester prodrugs of prostaglandin F2 alpha.
    Cheng-Bennett A; Chan MF; Chen G; Gac T; Garst ME; Gluchowski C; Kaplan LJ; Protzman CE; Roof MB; Sachs G
    Br J Ophthalmol; 1994 Jul; 78(7):560-7. PubMed ID: 7918269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular penetration and bioconversion of prostaglandin F2alpha prodrugs in rabbit cornea and conjunctiva.
    Chien DS; Tang-Liu DD; Woodward DF
    J Pharm Sci; 1997 Oct; 86(10):1180-6. PubMed ID: 9344177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the FP-receptor as a discrete entity by radioligand binding in biosystems that exhibit different functional rank orders of potency in response to prostanoids.
    Woodward DF; Fairbairn CE; Lawrence RA
    Adv Exp Med Biol; 1997; 400A():223-7. PubMed ID: 9547561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
    Bhattacherjee P; Williams BS; Paterson CA
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes.
    Crankshaw DJ; Gaspar V
    J Reprod Fertil; 1995 Jan; 103(1):55-61. PubMed ID: 7535849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioligand binding analysis of receptor subtypes in two FP receptor preparations that exhibit different functional rank orders of potency in response to prostaglandins.
    Woodward DF; Fairbairn CE; Krauss AH; Lawrence RA; Protzman CE
    J Pharmacol Exp Ther; 1995 Apr; 273(1):285-7. PubMed ID: 7714778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.
    Sharif NA; Williams GW; Crider JY; Xu SX; Davis TL
    J Ocul Pharmacol Ther; 2004 Dec; 20(6):489-508. PubMed ID: 15684809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships and receptor profiles of some ocular hypotensive prostanoids.
    Resul B; Stjernschantz J; Selén G; Bito L
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S47-52. PubMed ID: 9154276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin F2 alpha effects on intraocular pressure negatively correlate with FP-receptor stimulation.
    Woodward DF; Burke JA; Williams LS; Palmer BP; Wheeler LA; Woldemussie E; Ruiz G; Chen J
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1838-42. PubMed ID: 2759797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2-Glyceryl Ester: In Vivo Evidence for a Distinct Pharmacological Identity from Intraocular Pressure Studies.
    Woodward DF; Poloso NJ; Wang JW
    J Pharmacol Exp Ther; 2016 Aug; 358(2):173-80. PubMed ID: 27217589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2.
    Giles H; Bolofo ML; Lydford SJ; Martin GR
    Br J Pharmacol; 1991 Oct; 104(2):541-9. PubMed ID: 1665742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a single (FP) receptor associated with prostanoid-induced Ca2+ signals in Swiss 3T3 cells.
    Woodward DF; Lawrence RA
    Biochem Pharmacol; 1994 Apr; 47(9):1567-74. PubMed ID: 8185669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.
    Sharif NA; McLaughlin MA; Kelly CR; Xu S; Crider JY; Williams GW; Parker JL
    J Ocul Pharmacol Ther; 2006 Oct; 22(5):291-309. PubMed ID: 17076623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
    Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
    J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents.
    Resul B; Stjernschantz J; No K; Liljebris C; Selén G; Astin M; Karlsson M; Bito LZ
    J Med Chem; 1993 Jan; 36(2):243-8. PubMed ID: 8423596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.